WVE Latest Press Releases

-- October 27, 2026 --

Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update Globe Newswire 7:30 AM

-- October 20, 2026 --

Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026 Globe Newswire 8:30 AM

-- October 19, 2026 --

Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026 Globe Newswire 8:30 AM

-- October 13, 2026 --

Wave Life Sciences to Present at Chardan's 10th Annual Healthcare Conference Globe Newswire 8:30 AM

-- October 1, 2026 --

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD Globe Newswire 7:30 AM

-- September 30, 2026 --

Wave Life Sciences Announces GSK's Selection of siRNA program to Transition to GSK for Further Development Globe Newswire 7:30 AM

-- September 23, 2026 --

Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity Globe Newswire 7:30 AM

-- September 22, 2026 --

Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer Globe Newswire 7:30 AM

-- September 3, 2026 --

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference Globe Newswire 4:05 PM

-- August 10, 2026 --

Wave Life Sciences Announces Completion of Redomiciliation to Delaware Globe Newswire 8:30 AM

-- August 5, 2026 --

Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware Globe Newswire 4:05 PM

-- August 4, 2026 --

Wave Life Sciences to Present at Upcoming Investor Conferences Globe Newswire 8:30 AM

-- July 30, 2026 --

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 7:30 AM

-- July 23, 2026 --

Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026 Globe Newswire 8:30 AM

-- July 7, 2026 --

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation Globe Newswire 4:15 PM

-- June 24, 2026 --

Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes